Ledys, Fanny <br/><br/>
Anti-MEK and Anti-EGFR mAbs in RAS-Mutant Metastatic Colorectal Cancer: Case Series and Rationale.  [electronic resource] 

 -  Advances in therapy  06 2019 
 - 1480-1484 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1865-8652 
<br/><br/><label>Standard No.: </label>10.1007/s12325-019-00949-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Cetuximab--therapeutic use<br/>Colorectal Neoplasms--drug therapy<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Humans<br/>Male<br/>Mice<br/>Middle Aged<br/>Mitogen-Activated Protein Kinases--antagonists & inhibitors<br/>Neoplasm Metastasis--drug therapy<br/>Proto-Oncogene Proteins B-raf--drug effects<br/>Pyridones--therapeutic use<br/>Pyrimidinones--therapeutic use<br/>Rats